TY - JOUR
T1 - Impairment of Hemostasis in Patients With Severe Hemophilia
T2 - Failure of Diphenhydramine, Chlorpromazine, and Guaifenesin
AU - Buchanan, G. R.
AU - Handin, R. I.
PY - 1978/11/10
Y1 - 1978/11/10
N2 - Twenty-three patients with severe hemophilia were given single or multiple doses of diphenhydramine hydrochloride, chlorpromazine hydrochloride, or guaifenesin to test their effects on hemostasis. In contrast with earlier studies with aspirin, bleeding times were not prolonged after ingestion of these three drugs. No patient had hemorrhage because of the drugs, and none recalled excessive bleeding following drug ingestion. These results greatly extend the clinical implications of prior observations carried out in normal subjects demonstrating that many antiplatelet drugs have no effects on in vivo hemostasis. We conclude that these drugs are probably safe for patients with bleeding disorders like hemophilia.
AB - Twenty-three patients with severe hemophilia were given single or multiple doses of diphenhydramine hydrochloride, chlorpromazine hydrochloride, or guaifenesin to test their effects on hemostasis. In contrast with earlier studies with aspirin, bleeding times were not prolonged after ingestion of these three drugs. No patient had hemorrhage because of the drugs, and none recalled excessive bleeding following drug ingestion. These results greatly extend the clinical implications of prior observations carried out in normal subjects demonstrating that many antiplatelet drugs have no effects on in vivo hemostasis. We conclude that these drugs are probably safe for patients with bleeding disorders like hemophilia.
UR - http://www.scopus.com/inward/record.url?scp=0018135444&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0018135444&partnerID=8YFLogxK
U2 - 10.1001/jama.1978.03290200051021
DO - 10.1001/jama.1978.03290200051021
M3 - Article
C2 - 702728
AN - SCOPUS:0018135444
SN - 0098-7484
VL - 240
SP - 2173
EP - 2174
JO - JAMA: The Journal of the American Medical Association
JF - JAMA: The Journal of the American Medical Association
IS - 20
ER -